She is a physician with formal training in epidemiology and a fellowship in clinical pharmacology. Her main research interest is drug safety and efficacy. She is focused on understanding the genetic contribution to drug response variability, particularly cardio-metabolic responses, during physiological and pathological conditions. She plans to study the genetic architecture of glucocorticoid response using a reproducible, easily measured in vivo pharmacodynamic effect of glucocorticoids in a large clinical-based DNA biobank (BioVU) and through a clinical research study.